Opportunity ID: 304920

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-CA-18-014
Funding Opportunity Title: Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R21 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 10, 2018
Last Updated Date:
Original Closing Date for Applications: Aug 16, 2018
Current Closing Date for Applications: Aug 16, 2018
Archive Date: Sep 21, 2018
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: City or township governments
Public and State controlled institutions of higher education
For profit organizations other than small businesses
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Independent school districts
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
State governments
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of the funding opportunity announcement (FOA) is to advance our understanding of the modes of transmission of Kaposi sarcoma-associated herpesvirus (KSHV), also called human herpesvirus-8 (HHV-8); the biology of the initial steps of infection; and risk factors for infection to inform efforts to prevent KSHV transmission and thus prevent Kaposi sarcoma (KS), KSHV-associated multicentric Castleman disease (MCD), primary effusion lymphoma (PEL), and other KSHV-induced diseases in populations living with HIV or at high risk of developing HIV.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-014.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E FORMS-E PKG00241963 Jul 16, 2018 Aug 16, 2018 View

Package 1

Mandatory forms

304920 RR_SF424_2_0-2.0.pdf

304920 PHS398_CoverPageSupplement_4_0-4.0.pdf

304920 RR_OtherProjectInfo_1_4-1.4.pdf

304920 PerformanceSite_2_0-2.0.pdf

304920 RR_KeyPersonExpanded_2_0-2.0.pdf

304920 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

304920 RR_Budget_1_4-1.4.pdf

304920 RR_SubawardBudget30_1_4-1.4.pdf

304920 PHS398_ModularBudget_1_2-1.2.pdf

304920 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-09T13:37:50-05:00

Share This Post, Choose Your Platform!

About the Author: